NCT02451865View on ClinicalTrials.gov

Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2019

Conditions

Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer

Interventions

DRUG

Binimetinib

Given PO

DRUG

Docetaxel

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER